Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Darren Sigal, MD

Accepting New Patients

(204 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of California, Los Angeles (UCLA), David Geffen School of Medicine (2002)

326 Santa Fe Drive
Encinitas, CA 92024

(760) 753-5594

Dr. Darren Sigal, MD is a medical oncologist in Encinitas, CA specializing in medical oncology, adult oncology and adult hematology. He graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine in 2002 and has 23 years of experience. Dr. Darren Sigal, MD is affiliated with Scripps Health and Scripps Green Hospital.

Office Locations

Address:

326 Santa Fe Drive
Encinitas, CA 92024

Address:

15004 Innovation Drive
San Diego, CA 92128

Address:

10710 North Torrey Pines Road
La Jolla, CA 92037

In The News (see more mentions in the news)

“Only about 20 percent of hepatocellular cancer patients respond to checkpoint inhibitors, Dr. Darren Sigal, principal investigator of the study, said in a statement.”—"Experimental liver cancer drug developed at Scripps Research cleared for testing", The San Diego Union-Tribune, May 2019

“Lutathera treatment is available to patients at the Scripps MD Anderson Cancer Center, with Xavier and Scripps hematologist and medical oncologist Dr. Darren Sigal serving as the therapy's ordering...”—"San Diego Resident Becomes First in County to Receive Radioactive Cancer Drug", Times of San Diego, November 2018

“Dr. Darren Sigal will be recognized during the pregame ceremony before Tuesday night's San Diego Padres-Miami Marlins game at Petco Park for his pioneering work in pancreatic cancer research.”—"Padres to Honor Cancer Researcher at Miami Marlins Game", Times of San Diego, June 2016

biological response modifier (BRM) therapy	526
chemotherapy	526
doctor visit	1268
hospital care	66
inpatient care	66
minimally invasive procedures	653
port flush	77

**Gender**
Male	264
Female	275

**Ethnicity**
Non-Hispanic White	460
Black	0
Hispanic	28
Asian	31
Other	0
Native American	0

**Age**
From 65 to 74	234
From 75 to 84	193
85 and over	76
Less than 65	36

Hypertension	57
High Cholesterol	45
Stroke	4
Ischemic Heart Disease	34
Depression	21
Chronic Kidney Disease	33
Asthma	4
Osteoperosis	8
Atrial Fibrilation	16
Heart Failure	20
Chronic Obstructive Pulmonary Disease	11
Diabetes	25
Dementia	6
Cancer	41

biological response modifier (BRM) therapy	587
chemotherapy	587
doctor visit	1355
hormone therapy	25
hospital care	58
inpatient care	58
minimally invasive procedures	729
port flush	104

**Gender**
Male	274
Female	315

**Ethnicity**
Non-Hispanic White	512
Black	0
Hispanic	27
Asian	31
Other	0
Native American	0

**Age**
From 65 to 74	252
From 75 to 84	205
85 and over	92
Less than 65	40

biological response modifier (BRM) therapy	610
blood draw	13
chemotherapy	610
doctor visit	1292
hormone therapy	29
hospital care	64
inpatient care	64
minimally invasive procedures	698
port flush	97

**Gender**
Male	560
Female	604

**Ethnicity**
Non-Hispanic White	1000
Black	0
Hispanic	52
Asian	66
Other	0
Native American	0

**Age**
From 65 to 74	518
From 75 to 84	408
85 and over	162
Less than 65	76

Hypertension	60
High Cholesterol	48
Stroke	6
Ischemic Heart Disease	35
Depression	20
Chronic Kidney Disease	32
Asthma	8
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	18
Chronic Obstructive Pulmonary Disease	12
Diabetes	26
Dementia	4
Cancer	41

biological response modifier (BRM) therapy	588
chemotherapy	588
doctor visit	1289
hormone therapy	54
hospital care	38
inpatient care	38
minimally invasive procedures	719
port flush	55

**Gender**
Male	293
Female	328

**Ethnicity**
Non-Hispanic White	527
Black	0
Hispanic	30
Asian	40
Other	0
Native American	0

**Age**
From 65 to 74	273
From 75 to 84	213
85 and over	93
Less than 65	42

Hypertension	60
High Cholesterol	46
Stroke	6
Ischemic Heart Disease	33
Depression	21
Chronic Kidney Disease	35
Asthma	15
Osteoperosis	10
Atrial Fibrilation	13
Heart Failure	17
Chronic Obstructive Pulmonary Disease	13
Diabetes	24
Dementia	6
Cancer	38

biological response modifier (BRM) therapy	627
blood draw	13
chemotherapy	627
doctor visit	1367
hormone therapy	36
hospital care	49
inpatient care	49
minimally invasive procedures	772
port flush	109

**Gender**
Male	307
Female	336

**Ethnicity**
Non-Hispanic White	556
Black	0
Hispanic	23
Asian	36
Other	0
Native American	0

**Age**
From 65 to 74	269
From 75 to 84	244
85 and over	90
Less than 65	40

biological response modifier (BRM) therapy	641
chemotherapy	641
doctor visit	1375
hormone therapy	40
hospital care	60
inpatient care	60
minimally invasive procedures	715
port flush	63

**Gender**
Male	257
Female	282

**Ethnicity**
Non-Hispanic White	465
Black	0
Hispanic	26
Asian	22
Other	0
Native American	0

**Age**
From 65 to 74	234
From 75 to 84	194
85 and over	73
Less than 65	38

biological response modifier (BRM) therapy	691
blood draw	10
chemotherapy	691
doctor visit	1351
hormone therapy	18
hospital care	59
inpatient care	59
minimally invasive procedures	758
port flush	76

**Gender**
Male	278
Female	306

**Ethnicity**
Non-Hispanic White	496
Black	0
Hispanic	31
Asian	30
Other	0
Native American	0

**Age**
From 65 to 74	239
From 75 to 84	235
85 and over	76
Less than 65	34

biological response modifier (BRM) therapy	764
chemotherapy	764
doctor visit	1374
hospital care	28
inpatient care	28
minimally invasive procedures	804
port flush	96

**Gender**
Male	267
Female	257

**Ethnicity**
Non-Hispanic White	436
Black	0
Hispanic	26
Asian	33
Other	0
Native American	0

**Age**
From 65 to 74	222
From 75 to 84	203
85 and over	68
Less than 65	31

Hypertension	57
High Cholesterol	52
Stroke	5
Ischemic Heart Disease	34
Depression	23
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	14
Atrial Fibrilation	18
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	24
Dementia	7
Cancer	46

biological response modifier (BRM) therapy	619
chemotherapy	619
doctor visit	1264
hormone therapy	14
hospital care	51
inpatient care	51
minimally invasive procedures	700
port flush	79

**Gender**
Male	251
Female	269

**Ethnicity**
Non-Hispanic White	427
Black	0
Hispanic	26
Asian	33
Other	0
Native American	0

**Age**
From 65 to 74	233
From 75 to 84	202
85 and over	59
Less than 65	26

biological response modifier (BRM) therapy	782
blood draw	17
chemotherapy	782
doctor visit	1317
hospital care	23
inpatient care	23
minimally invasive procedures	779
port flush	150

**Gender**
Male	269
Female	278

**Ethnicity**
Non-Hispanic White	458
Black	0
Hispanic	0
Asian	32
Other	27
Native American	0

**Age**
From 65 to 74	233
From 75 to 84	211
85 and over	76
Less than 65	27

Hypertension	65
High Cholesterol	67
Stroke	8
Ischemic Heart Disease	29
Depression	22
Chronic Kidney Disease	26
Asthma	9
Osteoperosis	21
Atrial Fibrilation	22
Heart Failure	19
Chronic Obstructive Pulmonary Disease	15
Diabetes	26
Dementia	6
Cancer	48

Average Medicare Procedure Volume From 2013 - 2022

Volume of procedures performed by Dr. Darren Sigal, MD for Medicare patients.

The highest averages for the top procedures that Dr. Darren Sigal, MD treated as a medical oncologist in Encinitas, CA were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

biological response modifier (BRM) therapy	644
blood draw	14
chemotherapy	644
doctor visit	1325
hormone therapy	30
hospital care	49
inpatient care	49
minimally invasive procedures	733

Average Medicare Patient Data From 2013 - 2022

Information about Medicare patients treated by Dr. Darren Sigal, MD.

**Gender**
Male	302
Female	325

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	35
Non-Hispanic White	533
Native American / Alaskan Native	0
Hispanic	26
Other	2

**Age**
75 to 84	230
85 and over	86
Less than 65	39
65 to 74	270

Average of Total of Conditions of Medicare patients treated by Dr. Darren Sigal, MD From 2013 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Darren Sigal, MD treated were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension	58
High Cholesterol	49
Stroke	5
Ischemic Heart Disease	34
Depression	22
Chronic Kidney Disease	33
Asthma	7
Osteoporosis	12
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	24
Atrial Fibrillation	15
Cancer	41
Dementia	6

Education & Training

Dr. Darren Sigal, MD graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine in 2002. He completed residency at University of California, Davis Affiliated Hospitals. He is certified by the American Board of Internal Medicine, Medical Oncology, American Board of Internal Medicine and has a state license in California.

Medical School: University of California, Los Angeles (UCLA), David Geffen School of Medicine (2002)

Residency: University of California, Davis Affiliated Hospitals (2005)

Board Certification: American Board of Internal Medicine, Medical Oncology, American Board of Internal Medicine (2008)

Licensed In: California

Affiliations & Hospitals

Dr. Darren Sigal, MD is associated with these hospitals and organizations:

Scripps Health

Scripps Green Hospital

Ratings & Reviews

Dr. Darren Sigal, MD has an exceptional overall rating with an average of 4.9 out of 5 stars based on 204 ratings. We collect ratings and reviews of Dr. Darren Sigal, MD from all over the web to help you find the right in Encinitas, CA.

4.9

Overall Rating

(204 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Darren Sigal, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Celularity Inc.	$75,934 $75,934
Celgene Corporation	$74,023 Abraxane $73,786	Revlimid $150	Pomalyst $43	Istodax $27	Inrebic $16
Ipsen Biopharmaceuticals, Inc	$71,023 ONIVYDE $53,147	Somatuline Depot $17,818	Somatuline Depot 120mg-.5ml $58
Bayer HealthCare Pharmaceuticals Inc.	$52,557 Vitrakvi $27,921	Stivarga $16,042	Nexavar $8,310	Xofigo $218	Aliqopa $47	Other $20
Seagen Inc.	$28,755 TUKYSA $28,755
Other	$64,998 PEGPH20 $4,784	Avastin $4,448	Lupron $4,263	Non-Covered Product $4,065	Creon $3,223	Other $44,216

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$185,810
Current or prospective ownership or investment interest	$74,500
Consulting Fee	$52,167
Food and Beverage	$21,747
Travel and Lodging	$20,135
Other	$12,932

Research Payments

Dr. Darren Sigal, MD has received 470 research payments totaling $2,102,512.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Darren Sigal, MD.

Celularity Inc.

2022

$16,056.58

Physician Covered Recipient

Restricted stock and stock options

Biography

Dr. Darren Sigal specializes in adult hematology, adult oncology, and medical oncology and practices in La Jolla, CA, San Diego, CA, and Encinitas, CA. Dr. Sigal's patients gave him an average rating of 5.0 stars (out of 5). He attended the University of California, Los Angeles (UCLA), David Geffen School of Medicine and then went on to complete his residency at a hospital affiliated with the University of California, Davis. He is affiliated with Scripps Green Hospital. According to Scripps Health, new patients are welcome to contact Dr. Sigal's office in San Diego, CA.